Get everything you need to know about the Aprameya Engineering IPO. Explore Aprameya Engineering IPO details, including IPO dates, financial statements, valuation, peer comparison, and more.
Aprameya Engineering Limited specializes in the installation, setup, and maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatres, dialysis centers, and prefabricated structure wards. These healthcare infrastructure projects are undertaken on a turnkey basis, and the company also supplies high-value healthcare and diagnostic equipment to private and government hospitals, as well as medical practitioners. The company has expanded its operations to include setting up healthcare infrastructure and trading medical equipment, with a focus on providing turnkey healthcare solutions since 2020.
Key Points:
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
Fields | Details |
---|---|
IPO Dates | 25 Jul - 29 Jul 2024 |
IPO Price Band | ₹ 56 - 58 per share |
Fresh Issue | 50,40,000 shares |
Offer For Sale | NIL |
Total IPO Size | Approx ₹ 29.23 crore |
Face Value | ₹ 10 |
Listing On | NSE |
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
Event | Date |
---|---|
IPO Opening Date | 25 Jul 2024 |
IPO Closing Date | 29 Jul 2024 |
Basis Of Allotment | 30 Jul 2024 |
Refunds | 31 Jul 2024 |
Demat Transfer | 31 Jul 2024 |
IPO Listing Date | 01 Aug 2024 |
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
Period Ended | 31st March 2021 | 31st March 2022 | 31st March 2023 | 31st March 2024 |
---|---|---|---|---|
Total Income | 26.01 | 200.26 | 78.33 | 65.62 |
Total Expenses | 24.46 | 176.13 | 70.85 | 61.03 |
Net Profit/Loss | 1.02 | 16.62 | 5.37 | 3.46 |
NPM (*) | 3.93 | 8.31 | 6.87 | 5.30 |
Total Assets | 10.87 | 48.71 | 61.89 | 75.60 |
Total Liabilities | 7.14 | 34.18 | 41.97 | 52.24 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Uncover significant valuation metrics such as EPS (Earnings Per Share), ROE (Return on Equity), ROCE (Return on Capital Employed), D/E Ratio (Debt-to-Equity Ratio), Current Ratio, and EBITDA Margin. These key indicators offer insights into the company's financial standing and performance, aiding in informed investment decisions.
Period Ended | 31st March 2021 | 31st March 2022 | 31st March 2022 | 31st March 2024 |
---|---|---|---|---|
EPS | 0.73 | 11.87 | 3.84 | 2.47 |
ROE (%) | 28.97 | 182.04 | 31.17 | 15.97 |
ROCE (%) | 46.31 | 88.38 | 18.22 | 9.60 |
D/E Ratio | 0.40 | 0.94 | 1.44 | 1.80 |
Current Ratio | 1.32 | 2.06 | 1.87 | 1.77 |
EBITDA MARGIN (%) | 9.26 | 12.38 | 11.20 | 9.10 |
* Compiled from DRHP/RHP for valuation purposes.
No listed peers available for comparison.
Investor Type | Subscribed |
---|---|
Qualified Institutional Buyer (QIB) | 90.29 |
Non-Institutional Investor (NII/HNI) | 339.99 |
Retail Individual Investor (RII) | 187.88 |
Total | 192.57 |
* All figures represent multiples of the subscription. Check subscriptions for other ongoing issues here.
MUFG Intime India Private Limited (Formerly known as Link Intime India Private Limited)
Phone: + 91 810 811 4949
Email: ipo.helpdesk@linkintime.co.in
Website: https://linkintime.co.in/
Aprameya Engineering Limited
908, 9th Floor, Venus Atlantis Corporate Park, Anandnagar, Prahladnagar, Ahmedabad, Gujarat380015 India.
Phone: + 079-40068827
Email: cs@aelhealth.com
Website: www.aelhealth.com